$Etanercept in The Treatment of Active Refractory Crohn's Disease: A Single-Center Pilot Trial$

Etanercept in The Treatment of Active Refractory Crohn's Disease: A Single-Center Pilot Trial

Etanercept, an injectable tumor necrosis factor (TNF) receptor fusion protein, binds and inactivates human TNF and is used in active rheumatoid arthritis. Blocking TNF with monoclonal antibodies has also been beneficial in Crohn's disease. We attempted to determine the efficacy and safety of et...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of gastroenterology 2001-09, Vol.96 (9), p.2564-2568
Hauptverfasser:	D'Haens, Geert, Swijsen, Caroline, Noman, Maja, Lemmens, Liesbeth, Ceuppens, Jan, Agbahiwe, H., Geboes, Karel, Rutgeerts, Paul
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Biological and medical sciences Crohn Disease - drug therapy Crohn Disease - pathology Digestive system Etanercept Female Gastroenterology Humans Immunoglobulin G - therapeutic use Immunosuppressive Agents - therapeutic use Male Medical sciences Middle Aged Pharmacology. Drug treatments Pilot Projects Receptors, Tumor Necrosis Factor - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!